These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 31781928)

  • 41. Characterisation of the spectrum of demyelinating disease in Western Australia.
    Wu JS; Zhang MN; Carroll WM; Kermode AG
    J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1022-6. PubMed ID: 18356258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dynamic changes in patient admission and their disabilities in multiple sclerosis and neuromyelitis optica: A Japanese nationwide administrative data study.
    Matsumoto Y; Tarasawa K; Misu T; Namatame C; Takai Y; Kuroda H; Fujihara K; Fushimi K; Fujimori K; Aoki M
    Mult Scler Relat Disord; 2024 Jan; 81():105349. PubMed ID: 38043366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prevalence of long spinal cord lesions and anti-aquaporin 4 antibodies in neuromyelitis optica patients in Taiwan.
    Wang KC; Tsai CP; Lee CL; Chen SY; Chen SJ
    Eur Neurol; 2011; 65(2):99-104. PubMed ID: 21273778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Specificities of Children with Multiple Sclerosis and Neuromyelitis Optica.
    Fragoso YD
    Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):16-20. PubMed ID: 26654228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis.
    de Seze J; Lebrun C; Stojkovic T; Ferriby D; Chatel M; Vermersch P
    Mult Scler; 2003 Oct; 9(5):521-5. PubMed ID: 14582780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optic neuritis.
    Pau D; Al Zubidi N; Yalamanchili S; Plant GT; Lee AG
    Eye (Lond); 2011 Jul; 25(7):833-42. PubMed ID: 21527960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the retinal nerve fiber layer in neuromyelitis optica spectrum disorders: A systematic review and meta-analysis.
    Peng A; Qiu X; Zhang L; Zhu X; He S; Lai W; Chen L
    J Neurol Sci; 2017 Dec; 383():108-113. PubMed ID: 29246594
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Devic's neuromyelitis optica: diagnosis after 10 years of bilateral severe relapsing optic neuritis].
    Déral-Stéphant V; Roux-Lelièvre C; Vignal R; Stéphant E; Faivre A; Alla P
    J Fr Ophtalmol; 2008 Sep; 31(7):705-9. PubMed ID: 18971856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The retinal nerve fiber layer of patients with neuromyelitis optica and chronic relapsing optic neuritis is more severely damaged than patients with multiple sclerosis.
    Bichuetti DB; de Camargo AS; Falcão AB; Gonçalves FF; Tavares IM; de Oliveira EM
    J Neuroophthalmol; 2013 Sep; 33(3):220-4. PubMed ID: 23917443
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bilateral and recurrent optic neuritis in multiple sclerosis.
    Burman J; Raininko R; Fagius J
    Acta Neurol Scand; 2011 Mar; 123(3):207-10. PubMed ID: 20569226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
    de Sèze J; Kremer L; Collongues N
    Rev Neurol (Paris); 2016; 172(4-5):256-62. PubMed ID: 27157418
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The progress of research on the immune pathogenesis and biomarkers in optic neuritis related to neuromyelitis optica].
    Liu WD; Yu MY; Jiang LB
    Zhonghua Yan Ke Za Zhi; 2019 Mar; 55(3):228-233. PubMed ID: 30841690
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Optic neuropathy in positive anti-MOG antibody syndrome].
    Merabtene L; Vignal Clermont C; Deschamps R
    J Fr Ophtalmol; 2019 Dec; 42(10):1100-1110. PubMed ID: 31732265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A benign form of neuromyelitis optica: does it exist?
    Collongues N; Cabre P; Marignier R; Zéphir H; Papeix C; Audoin B; Lebrun-Frenay C; Pelletier J; Fontaine B; Vermersch P; Confavreux C; de Seze J;
    Arch Neurol; 2011 Jul; 68(7):918-24. PubMed ID: 21747032
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
    Banwell B; Tenembaum S; Lennon VA; Ursell E; Kennedy J; Bar-Or A; Weinshenker BG; Lucchinetti CF; Pittock SJ
    Neurology; 2008 Jan; 70(5):344-52. PubMed ID: 18094334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].
    Yang Y; Wu WP; Huang DH; Wu L
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(43):3032-5. PubMed ID: 23328372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of comorbidities and health care resource use among patients with highly active neuromyelitis optica.
    Ajmera MR; Boscoe A; Mauskopf J; Candrilli SD; Levy M
    J Neurol Sci; 2018 Jan; 384():96-103. PubMed ID: 29249387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical features and outcome of childhood optic neuritis at Queen Sirikit National Institute of Child Health.
    Sri-udomkajorn S; Pongwatcharaporn K
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S189-94. PubMed ID: 22043775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidemiology, immunopathogenesis and management of pediatric central nervous system inflammatory demyelinating conditions.
    Pohl D
    Curr Opin Neurol; 2008 Jun; 21(3):366-72. PubMed ID: 18451724
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Anti-MOG antibody in different types of immune-mediated optic neuritis].
    Kong XY; Peng JT; Liu LJ; Yan R; Zhang XJ
    Zhonghua Yan Ke Za Zhi; 2012 Dec; 48(12):1069-72. PubMed ID: 23336409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.